Cargando…

Editorial Comment: Impact of the advent of collagenase clostridium histolyticum on the surgical management of Peyronie's disease: a population-based analysis

Detalles Bibliográficos
Autores principales:	Sukumar, S, Pijush, DB, Brandes, S, Javaroni, Valter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2020
Materias:	Update in Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088505/ https://www.ncbi.nlm.nih.gov/pubmed/32167716 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.03.05

Ejemplares similares

Editorial Comment: Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment
por: Wymer, K, et al.
Publicado: (2020)

Editorial comment: Is testosterone replacement an effective treatment of secondary premature ejaculation?
por: Javaroni, Valter
Publicado: (2021)

Editorial Comment: The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction
por: Javaroni, Valter
Publicado: (2020)

Editorial Comment: Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care
por: Javaroni, Valter
Publicado: (2020)

Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015)

Editorial Comment: Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review
por: Javaroni, Valter
Publicado: (2020)

Editorial Comment: A Contemporary Analysis of Dual Inflatable Penile Prosthesis and Artificial Urinary Sphincter Outcomes
por: Javaroni, Valter
Publicado: (2020)

Editorial Comment: Erectile Dysfunction and Premature Ejaculation in Homosexual and Heterosexual Men: A Systematic Review and Meta-Analysis of Comparative Studies
por: Javaroni, Valter
Publicado: (2020)

Editorial Comment: Sexual Dysfunction in Parkinson Disease: A Multicenter Italian Cross-sectional Study on a Still Overlooked Problem
por: Javaroni, Valter
Publicado: (2021)

Editorial Comment: Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
por: Javaroni, Valter
Publicado: (2021)

Editorial Comment: Surgical Management of Peyronie's Disease With Co-Existent Erectile Dysfunction
por: Krishnappa, P, et al.
Publicado: (2020)

Editorial Comment: Penile prosthesis implant in the special populations: diabetics, neurogenic conditions, fibrotic cases, concurrent urinary continence surgery, and salvage implants
por: Chung, E, et al.
Publicado: (2020)

Editorial comment: Clinical Recommendations From the European Society for Sexual Medicine Exploring Partner Expectations, Satisfaction in Male and Phalloplasty Cohorts, the Impact of Penile Length, Girth and Implant Type, Reservoir Placement, and the Influence of Comorbidities and Social Circumstances
por: Javaroni, Valter
Publicado: (2021)

Safety of Xiaflex® (Collagenase Clostridium histolyticum) Treatment for Adult Anterior Urethral Stricture Disease
por: Wiegand, Lucas R, et al.
Publicado: (2023)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017)

AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States
por: Sun, Andrew J., et al.
Publicado: (2019)

Peyronie’s disease – outcomes of collagenase clostridium histolyticum injection: A systematic review
por: Mefford, Austin T., et al.
Publicado: (2021)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie’s disease
por: Diao, Linley, et al.
Publicado: (2017)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie’s disease
por: Aliperti, Louis A., et al.
Publicado: (2017)

Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2022)

Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum
por: Geelhoed, Jeannette P., et al.
Publicado: (2022)

Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study
por: Cocci, Andrea, et al.
Publicado: (2021)

Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option
por: Gabrielson, Andrew T, et al.
Publicado: (2017)

Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease
por: Melgarejo-Segura, Mª Teresa, et al.
Publicado: (2021)

Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners
por: Goldstein, Irwin, et al.
Publicado: (2017)

Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kadioglu, Ates, et al.
Publicado: (2017)

Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort study
por: Hu, Ming-Yeah Y., et al.
Publicado: (2022)

Editorial Comment: Sexual Function Outcomes After Surgical Treatment of Penile Fracture
por: de Castro, Rodrigo Barros
Publicado: (2022)

Editorial Comment: Embryological Development and Topographic Anatomy of Pelvic Compartments-Surgical Relevance for Pelvic Lymphonodectomy
por: Logsdon, Natasha T., et al.
Publicado: (2022)

Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kahn, Barbara, et al.
Publicado: (2017)

Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum
por: Kaminetsky, J., et al.
Publicado: (2018)

How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie's Disease Receiving Collagenase Clostridium Histolyticum Therapy?
por: Cocci, Andrea, et al.
Publicado: (2020)

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
por: Zhang, Fuxun, et al.
Publicado: (2022)

Penile surgery for patients with Peyronie’s disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis
por: Trost, Landon, et al.
Publicado: (2022)

Editorial Comment: Validity of a patient-specific percutaneous nephrolithotomy (PCNL) simulated surgical rehearsal platform: impact on patient and surgical outcomes
por: Favorito, Luciano A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kh3sbmelfm2vkn5kden7rd5q96